Ophthalmic Steroids Drugs refer to the steroids drug for the Ophthalmic. A large class of important natural compounds are derived from steroids with a tetracyclic structure. These compounds are called steroids and they are found in all plants and animals. The most abundant steroid in animals is cholesterol C27H46O. The body can synthesize cholesterol, and it can easily absorb cholesterol from food through the intestinal wall. Cholesterol is related to the formation of gallstones, which also harden the arteries. Biochemical changes and degradation of cholesterol produce many steroids that are important in human biochemistry.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Steroids Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Steroids Drug. This report contains market size and forecasts of Ophthalmic Steroids Drug in global, including the following market information:
Global Ophthalmic Steroids Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Ophthalmic Steroids Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Ophthalmic Steroids Drug companies in 2023 (%)
The global Ophthalmic Steroids Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Uveitis Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Steroids Drug include Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG and Regeneron Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Steroids Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Steroids Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, by Type, 2023 (%)
Uveitis
Diabetic Macular Edema
Allergic Conjunctivitis
Keratitis
Others
Global Ophthalmic Steroids Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Research Institute
Others
Global Ophthalmic Steroids Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Steroids Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Ophthalmic Steroids Drug revenues share in global market, 2023 (%)
Key companies Ophthalmic Steroids Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Ophthalmic Steroids Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch and Lomb
Alimera Sciences
Allergan
Novartis AG
GlaxoSmithKline
Genentech
Pfizer
Bayer AG
Regeneron Pharmaceuticals
Valeant Pharmaceuticals International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Steroids Drug, market overview.
Chapter 2: Global Ophthalmic Steroids Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Steroids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Steroids Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Steroids Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Steroids Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Steroids Drug Overall Market Size
2.1 Global Ophthalmic Steroids Drug Market Size: 2023 VS 2030
2.2 Global Ophthalmic Steroids Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Ophthalmic Steroids Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Ophthalmic Steroids Drug Players in Global Market
3.2 Top Global Ophthalmic Steroids Drug Companies Ranked by Revenue
3.3 Global Ophthalmic Steroids Drug Revenue by Companies
3.4 Global Ophthalmic Steroids Drug Sales by Companies
3.5 Global Ophthalmic Steroids Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Ophthalmic Steroids Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Ophthalmic Steroids Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Steroids Drug Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Steroids Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Steroids Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Steroids Drug Market Size Markets, 2023 & 2030
4.1.2 Uveitis
4.1.3 Diabetic Macular Edema
4.1.4 Allergic Conjunctivitis
4.1.5 Keratitis
4.1.6 Others
4.2 By Type - Global Ophthalmic Steroids Drug Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Steroids Drug Revenue, 2019-2024
4.2.2 By Type - Global Ophthalmic Steroids Drug Revenue, 2025-2030
4.2.3 By Type - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Ophthalmic Steroids Drug Sales & Forecasts
4.3.1 By Type - Global Ophthalmic Steroids Drug Sales, 2019-2024
4.3.2 By Type - Global Ophthalmic Steroids Drug Sales, 2025-2030
4.3.3 By Type - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
4.4 By Type - Global Ophthalmic Steroids Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Steroids Drug Market Size, 2023 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Research Institute
5.1.6 Others
5.2 By Application - Global Ophthalmic Steroids Drug Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Steroids Drug Revenue, 2019-2024
5.2.2 By Application - Global Ophthalmic Steroids Drug Revenue, 2025-2030
5.2.3 By Application - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Ophthalmic Steroids Drug Sales & Forecasts
5.3.1 By Application - Global Ophthalmic Steroids Drug Sales, 2019-2024
5.3.2 By Application - Global Ophthalmic Steroids Drug Sales, 2025-2030
5.3.3 By Application - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
5.4 By Application - Global Ophthalmic Steroids Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Ophthalmic Steroids Drug Market Size, 2023 & 2030
6.2 By Region - Global Ophthalmic Steroids Drug Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Steroids Drug Revenue, 2019-2024
6.2.2 By Region - Global Ophthalmic Steroids Drug Revenue, 2025-2030
6.2.3 By Region - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Ophthalmic Steroids Drug Sales & Forecasts
6.3.1 By Region - Global Ophthalmic Steroids Drug Sales, 2019-2024
6.3.2 By Region - Global Ophthalmic Steroids Drug Sales, 2025-2030
6.3.3 By Region - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Ophthalmic Steroids Drug Revenue, 2019-2030
6.4.2 By Country - North America Ophthalmic Steroids Drug Sales, 2019-2030
6.4.3 US Ophthalmic Steroids Drug Market Size, 2019-2030
6.4.4 Canada Ophthalmic Steroids Drug Market Size, 2019-2030
6.4.5 Mexico Ophthalmic Steroids Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Ophthalmic Steroids Drug Revenue, 2019-2030
6.5.2 By Country - Europe Ophthalmic Steroids Drug Sales, 2019-2030
6.5.3 Germany Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.4 France Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.5 U.K. Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.6 Italy Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.7 Russia Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.8 Nordic Countries Ophthalmic Steroids Drug Market Size, 2019-2030
6.5.9 Benelux Ophthalmic Steroids Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Ophthalmic Steroids Drug Revenue, 2019-2030
6.6.2 By Region - Asia Ophthalmic Steroids Drug Sales, 2019-2030
6.6.3 China Ophthalmic Steroids Drug Market Size, 2019-2030
6.6.4 Japan Ophthalmic Steroids Drug Market Size, 2019-2030
6.6.5 South Korea Ophthalmic Steroids Drug Market Size, 2019-2030
6.6.6 Southeast Asia Ophthalmic Steroids Drug Market Size, 2019-2030
6.6.7 India Ophthalmic Steroids Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Ophthalmic Steroids Drug Revenue, 2019-2030
6.7.2 By Country - South America Ophthalmic Steroids Drug Sales, 2019-2030
6.7.3 Brazil Ophthalmic Steroids Drug Market Size, 2019-2030
6.7.4 Argentina Ophthalmic Steroids Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ophthalmic Steroids Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Ophthalmic Steroids Drug Sales, 2019-2030
6.8.3 Turkey Ophthalmic Steroids Drug Market Size, 2019-2030
6.8.4 Israel Ophthalmic Steroids Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Ophthalmic Steroids Drug Market Size, 2019-2030
6.8.6 UAE Ophthalmic Steroids Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bausch and Lomb
7.1.1 Bausch and Lomb Company Summary
7.1.2 Bausch and Lomb Business Overview
7.1.3 Bausch and Lomb Ophthalmic Steroids Drug Major Product Offerings
7.1.4 Bausch and Lomb Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.1.5 Bausch and Lomb Key News & Latest Developments
7.2 Alimera Sciences
7.2.1 Alimera Sciences Company Summary
7.2.2 Alimera Sciences Business Overview
7.2.3 Alimera Sciences Ophthalmic Steroids Drug Major Product Offerings
7.2.4 Alimera Sciences Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.2.5 Alimera Sciences Key News & Latest Developments
7.3 Allergan
7.3.1 Allergan Company Summary
7.3.2 Allergan Business Overview
7.3.3 Allergan Ophthalmic Steroids Drug Major Product Offerings
7.3.4 Allergan Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.3.5 Allergan Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Ophthalmic Steroids Drug Major Product Offerings
7.4.4 Novartis AG Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.4.5 Novartis AG Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Ophthalmic Steroids Drug Major Product Offerings
7.5.4 GlaxoSmithKline Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Genentech
7.6.1 Genentech Company Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Ophthalmic Steroids Drug Major Product Offerings
7.6.4 Genentech Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.6.5 Genentech Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Ophthalmic Steroids Drug Major Product Offerings
7.7.4 Pfizer Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Ophthalmic Steroids Drug Major Product Offerings
7.8.4 Bayer AG Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Regeneron Pharmaceuticals
7.9.1 Regeneron Pharmaceuticals Company Summary
7.9.2 Regeneron Pharmaceuticals Business Overview
7.9.3 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Major Product Offerings
7.9.4 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.9.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.10 Valeant Pharmaceuticals International
7.10.1 Valeant Pharmaceuticals International Company Summary
7.10.2 Valeant Pharmaceuticals International Business Overview
7.10.3 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Major Product Offerings
7.10.4 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales and Revenue in Global (2019-2024)
7.10.5 Valeant Pharmaceuticals International Key News & Latest Developments
8 Global Ophthalmic Steroids Drug Production Capacity, Analysis
8.1 Global Ophthalmic Steroids Drug Production Capacity, 2019-2030
8.2 Ophthalmic Steroids Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Steroids Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Steroids Drug Supply Chain Analysis
10.1 Ophthalmic Steroids Drug Industry Value Chain
10.2 Ophthalmic Steroids Drug Upstream Market
10.3 Ophthalmic Steroids Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Steroids Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ophthalmic Steroids Drug in Global Market
Table 2. Top Ophthalmic Steroids Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Ophthalmic Steroids Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Ophthalmic Steroids Drug Revenue Share by Companies, 2019-2024
Table 5. Global Ophthalmic Steroids Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Ophthalmic Steroids Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Ophthalmic Steroids Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Ophthalmic Steroids Drug Product Type
Table 9. List of Global Tier 1 Ophthalmic Steroids Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Steroids Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Ophthalmic Steroids Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Ophthalmic Steroids Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Ophthalmic Steroids Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Ophthalmic Steroids Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Ophthalmic Steroids Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Ophthalmic Steroids Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Ophthalmic Steroids Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Ophthalmic Steroids Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Ophthalmic Steroids Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Ophthalmic Steroids Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Ophthalmic Steroids Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Ophthalmic Steroids Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Ophthalmic Steroids Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Ophthalmic Steroids Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Ophthalmic Steroids Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Ophthalmic Steroids Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Ophthalmic Steroids Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Ophthalmic Steroids Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Ophthalmic Steroids Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Ophthalmic Steroids Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Ophthalmic Steroids Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Ophthalmic Steroids Drug Sales, (K Units), 2025-2030
Table 46. Bausch and Lomb Company Summary
Table 47. Bausch and Lomb Ophthalmic Steroids Drug Product Offerings
Table 48. Bausch and Lomb Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Bausch and Lomb Key News & Latest Developments
Table 50. Alimera Sciences Company Summary
Table 51. Alimera Sciences Ophthalmic Steroids Drug Product Offerings
Table 52. Alimera Sciences Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Alimera Sciences Key News & Latest Developments
Table 54. Allergan Company Summary
Table 55. Allergan Ophthalmic Steroids Drug Product Offerings
Table 56. Allergan Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Allergan Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Ophthalmic Steroids Drug Product Offerings
Table 60. Novartis AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Novartis AG Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Ophthalmic Steroids Drug Product Offerings
Table 64. GlaxoSmithKline Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Genentech Company Summary
Table 67. Genentech Ophthalmic Steroids Drug Product Offerings
Table 68. Genentech Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Genentech Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Ophthalmic Steroids Drug Product Offerings
Table 72. Pfizer Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Pfizer Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Ophthalmic Steroids Drug Product Offerings
Table 76. Bayer AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Bayer AG Key News & Latest Developments
Table 78. Regeneron Pharmaceuticals Company Summary
Table 79. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Offerings
Table 80. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Regeneron Pharmaceuticals Key News & Latest Developments
Table 82. Valeant Pharmaceuticals International Company Summary
Table 83. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Offerings
Table 84. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Valeant Pharmaceuticals International Key News & Latest Developments
Table 86. Ophthalmic Steroids Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Ophthalmic Steroids Drug Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Ophthalmic Steroids Drug Production by Region, 2019-2024 (K Units)
Table 89. Global Ophthalmic Steroids Drug Production by Region, 2025-2030 (K Units)
Table 90. Ophthalmic Steroids Drug Market Opportunities & Trends in Global Market
Table 91. Ophthalmic Steroids Drug Market Drivers in Global Market
Table 92. Ophthalmic Steroids Drug Market Restraints in Global Market
Table 93. Ophthalmic Steroids Drug Raw Materials
Table 94. Ophthalmic Steroids Drug Raw Materials Suppliers in Global Market
Table 95. Typical Ophthalmic Steroids Drug Downstream
Table 96. Ophthalmic Steroids Drug Downstream Clients in Global Market
Table 97. Ophthalmic Steroids Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ophthalmic Steroids Drug Segment by Type in 2023
Figure 2. Ophthalmic Steroids Drug Segment by Application in 2023
Figure 3. Global Ophthalmic Steroids Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Steroids Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Ophthalmic Steroids Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Ophthalmic Steroids Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ophthalmic Steroids Drug Revenue in 2023
Figure 9. By Type - Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Ophthalmic Steroids Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Ophthalmic Steroids Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Ophthalmic Steroids Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Ophthalmic Steroids Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 23. US Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 28. Germany Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 37. China Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 44. Brazil Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Ophthalmic Steroids Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Ophthalmic Steroids Drug Sales Market Share, 2019-2030
Figure 48. Turkey Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Ophthalmic Steroids Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Ophthalmic Steroids Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Ophthalmic Steroids Drug by Region, 2023 VS 2030
Figure 54. Ophthalmic Steroids Drug Industry Value Chain
Figure 55. Marketing Channels
